MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • 2023 International Congress

    Discriminative properties and sensitivity to change of three cognitive assessment instruments in Huntington’s disease

    A. Horta-Barba, S. Martinez-Horta, J. Pérez-Pérez, A. Puig-Davi, N. de Lucia, G. de Michele, E. Salvatore, S. Kehrer, J. Priller, S. Migliore, F. Squitieri, A. Castaldo, C. Mariotti, V. Mañanes, J. Lopez-Sendon, N. Rodriguez, A. Martinez-Descals, F. Júlio, C. Januário, M. Delussi, M. de Tommaso, S. Noguera, J. Ruiz-Idiago, E. J. Sitek, R. Wallner, A. Nuzzi, J. Pagonabarraga, J. Kulisevsky, HD. Disease Network (BARCELONA, Spain)

    Objective: We addressed and compared the discriminative properties of different cognitive instruments, and we determined the sensitivity to change of the proposed assessments in the…
  • 2023 International Congress

    RNF216–associated neurodegeneration: Is it a new NBIA disorder?

    NS. Sriram (Banglore, India)

    Objective: To describe certain unique clinical and imaging features in a patient with RNF216-associated neuro degeneration (RNF216-AN) Background: RNF216-AN, known as Gordon Holmes syndrome is…
  • 2023 International Congress

    Epidemiological analysis of autosomal dominant chorea in Eastern Algeria

    Y. Mecheri, D. Satta, F. Serradj (Constantine, Algeria)

    Objective: We aim to analyze the main epidemiological characteristics of individuals having a Huntington disease phenotype in Eastern Algeria population. Background: Huntington's disease (HD) is…
  • 2023 International Congress

    Education level and the onset and severity of symptoms in Huntington’s disease

    SR. Zhang, YF. Cheng, XJ. Gu, KC. Liu, JY. Lin, TM. Yang, Y. Xiao, QR. Jiang, JX. Huang, QQ. Wei, RW. Ou, YB. Hou, LY. Zhang, CY. Li, JM. Burgunder, HF. Shang (Chengdu, China)

    Objective: The current study aimed to investigate the effect of educational level on the clinical characteristics of Chinese patients with Huntington’s disease (HD). Background: Education…
  • 2022 International Congress

    Anosognosia in HD: Comparison of Self-report and Caregiver Ratings with Objective Performance Measures

    SB. Hughes, A. Smirnova, A. Hall, C. Snell, B. Wright, PE. Gilbert, J. Corey-Bloom (San Diego, USA)

    Objective: Objective: To compare patient and caregiver report of cognitive, motoric, and psychiatric symptoms versus objective performance measures in patients with Huntington’s disease (HD). Background:…
  • 2022 International Congress

    Olfactory dysfunction in patients with Huntington disease

    J. Patino, H. Coco, S. Zadegan, S. Chandra, N. Karagas, N. Rocha, K. Anderson, A. Teixeira, E. Furr Stimming (Houston, USA)

    Objective: To investigate olfactory dysfunction (OD) in individuals with Huntington disease (HD) and its relation to disease severity. Background: HD is a hereditary neurodegenerative disease…
  • 2022 International Congress

    Profile and neural correlates of language disintegration in early Huntington’s disease

    S. Martinez-Horta, A. Puig-Davi, F. Sampedro, J. Perez-Perez, J. Matias-Guiu, A. Horta-Barba, J. Pagonabarraga, M. Diez-Cirarda, L. Fernandez-Romero, M. Yus, F. Cuetos, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore the language profile of early Huntington's disease (HD) and the neural correlates that accompany the development of linguistic alterations in HD. Background:…
  • 2022 International Congress

    Molecular diagnosis Approch for Huntington’s Disease in Tunisia

    H. Nehdi, E. Chebbi, F. Nabli, Z. Saied, S. Ben Sassi, R. Amouri (Tunis, Tunisia)

    Objective: The aim of this study is to establish a molecular diagnosis approach for huntington's Disease (HD) Background: Huntington's disease (HD) is a rare and…
  • 2022 International Congress

    A Useful Cognitive-Motor Dual Task Paradigm in Prodromal and Manifest HD

    EG. Churchill, J. Corey-Bloom, A. Hall, C. Snell, A. Smirnova, SB. Hughes, PE. Gilbert, DJ. Goble (San Diego, USA)

    Objective: To investigate whether a cognitive-motor dual task (DT) paradigm uncovers deficits in balance in Huntington’s disease (HD) and, more importantly, prodromal HD, compared to…
  • 2022 International Congress

    Feasibility of using ENROLL-HD for health services research: Evaluation of delays in Huntington’s Disease (HD) Diagnosis

    A. Mendizabal, S. Perlman, Y. Bordelon (LOS ANGELES, USA)

    Objective: To describe social and structural determinants of health of HD patients and to evaluate the feasibility of using this dataset for health services research.…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley